| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 1 Feb 2026 | 1 Feb 2026 |
| This is to inform that the Resolution Plan Implementation Committee, in its meeting held today, viz. Sunday, February 01, 2026, which commenced at 06:00 P.M. (IST) and concluded at 07:18 P.M. (IST) through a physical meeting, inter alia considered, noted and approved the audited consolidated financial results of the Company, for the half year and the year ended on March 31, 2025. | ||
| Board Meeting | 23 Jan 2026 | 19 Jan 2026 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 inter alia to consider and approve In compliance with the relevant provisions of Regulation 29 read with such other applicable provisions of the Listing Regulations subject to the provisions of the NCLT Order dated December 18 2025 along with the provisions of the Insolvency and Bankruptcy Code 2016 the Company hereby inform you that the duly constituted Resolution Plan Implementation Committee in its meeting scheduled to be held on Friday January 23 2026 to inter-alia consider discuss and approve the reduction/ cancellation and extinguishment of the existing paid-up share capital of the Company held by the erstwhile Promoters and the public shareholders as on the Record Date dated January 21 2026. This is to inform that the Resolution Plan Implementation Committee, in its meeting held today, viz. Friday, January 23, 2026, which commenced at 03:30 P.M. (IST) and concluded at 04:26 P.M. (IST) through video-conferencing, inter alia considered, discussed and approved: 1) reduction/cancellation and extinguishment of the existing equity shares held by the erstwhile Promoters (Erstwhile Promoters Shareholding); 2) reduction/cancellation and extinguishment of the existing equity shares held by the public shareholders as on the Record Date (Public Shareholding); and 3) allotment of fresh equity shares to the Public Shareholders. (As per BSE Announcement dated on: 23.01.2026) | ||
| Board Meeting | 14 Jan 2026 | 11 Jan 2026 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/01/2026 inter alia to consider and approve the Un-audited Consolidated Financial Results of the Company for the quarter and half year ended on September 30 2025 along with the Limited Review Report issued by S S R C A & Co. Chartered Accountants Statutory Auditors of the Company in compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 This is to inform that the Resolution Plan Implementation Committee, in its meeting held today, viz. Wednesday, January 14, 2026, which commenced at 03:30 P.M. (IST) and concluded at 03:53 P.M. (IST) through video-conferencing, inter alia considered, discussed and approved the un-audited consolidated financial results of the Company, for the half year ended on September 30, 2025. (As Per BSE Announcement Dated on: 14/01/2026) | ||
| Board Meeting | 9 Jan 2026 | 5 Jan 2026 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve a) the record date for reduction/cancellation and extinguishment of existing equity shares held by the erstwhile promoters and existing public shareholders of the Company (existing equity paid-up share capital); and b) issuance of equity shares on a preferential basis to the prospective promoters in compliance with the NCLT Order read with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended from time to time. This is to inform that the Implementation Committee, in its meeting held today, viz. Friday, January 09, 2026, which commenced at 03:00 P.M. (IST) and concluded at 03:46 P.M. (IST) through video-conferencing, inter alia considered, discussed and approved: 1. The Appointment of Directors on the Board of Directors of the Company (Interim Board); 2. The Record Date as Friday, January 16, 2026, for the purpose of reduction/cancellation and extinguishment of existing paid-up equity share capital held by the erstwhile promoters and existing public shareholders of the Company; and 3. Issuance of 2,37,50,000 (Two Crores Thirty-Seven Lakhs Fifty Thousand) fresh equity shares on a preferential basis, at a face value of INR 10/- (Indian Rupees Ten Only) each, which shall rank pari-passu basis in all respects with the existing equity shares to the prospective promoters of the Company, in accordance with the NCLT Order. (As Per BSE Announcement Dated on:09.01.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.